Central serous chorioretinopathy in giant cell arteritis

Vinay Shah; Sandeep Randhawa; H. Culver Boldt; Andrew G. Lee

doi:10.1080/08820530500511396

Central serous chorioretinopathy in giant cell arteritis

Vinay Shah, Sandeep Randhawa, H. Culver Boldt, Andrew G. Lee

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

A 66-year-old woman started oral prednisone for temporal artery biopsy (TAB) proven GCA and developed central haziness OD>OS. Visual acuity worsened to 20/100 OD and 20/25 OS. Clinical exam, optical coherence tomography (OCT) and fluorescein angiography (FA) revealed central serous chorioretinopathy (CSCR). The patient was treated with focal laser therapy for CSCR and steroid taper. Patients with giant cell arteritis on high dose steroids may present with significant loss of visual acuity and field. CSCR (precipitated by steroids) should be considered in the differential diagnosis as increasing the steroid dose for presumed visual loss secondary to GCA might worsen rather than improve the visual outcome.

Original language	English (US)
Pages (from-to)	45-48
Number of pages	4
Journal	Seminars in Ophthalmology
Volume	21
Issue number	1
DOIs	https://doi.org/10.1080/08820530500511396
State	Published - Jan 1 2006

Keywords

Central serous retinopathy
Chorioretinopathy
Corticosteroid
Giant cell arteritis
Steroids
Temporal arteritis

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1080/08820530500511396

Cite this

@article{b4d7dc598d7b431586b7a3a07e0c086d,

title = "Central serous chorioretinopathy in giant cell arteritis",

abstract = "A 66-year-old woman started oral prednisone for temporal artery biopsy (TAB) proven GCA and developed central haziness OD>OS. Visual acuity worsened to 20/100 OD and 20/25 OS. Clinical exam, optical coherence tomography (OCT) and fluorescein angiography (FA) revealed central serous chorioretinopathy (CSCR). The patient was treated with focal laser therapy for CSCR and steroid taper. Patients with giant cell arteritis on high dose steroids may present with significant loss of visual acuity and field. CSCR (precipitated by steroids) should be considered in the differential diagnosis as increasing the steroid dose for presumed visual loss secondary to GCA might worsen rather than improve the visual outcome.",

keywords = "Central serous retinopathy, Chorioretinopathy, Corticosteroid, Giant cell arteritis, Steroids, Temporal arteritis",

author = "Vinay Shah and Sandeep Randhawa and Boldt, {H. Culver} and Lee, {Andrew G.}",

year = "2006",

month = jan,

day = "1",

doi = "10.1080/08820530500511396",

language = "English (US)",

volume = "21",

pages = "45--48",

journal = "Seminars in Ophthalmology",

issn = "0882-0538",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Central serous chorioretinopathy in giant cell arteritis

AU - Shah, Vinay

AU - Randhawa, Sandeep

AU - Boldt, H. Culver

AU - Lee, Andrew G.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - A 66-year-old woman started oral prednisone for temporal artery biopsy (TAB) proven GCA and developed central haziness OD>OS. Visual acuity worsened to 20/100 OD and 20/25 OS. Clinical exam, optical coherence tomography (OCT) and fluorescein angiography (FA) revealed central serous chorioretinopathy (CSCR). The patient was treated with focal laser therapy for CSCR and steroid taper. Patients with giant cell arteritis on high dose steroids may present with significant loss of visual acuity and field. CSCR (precipitated by steroids) should be considered in the differential diagnosis as increasing the steroid dose for presumed visual loss secondary to GCA might worsen rather than improve the visual outcome.

AB - A 66-year-old woman started oral prednisone for temporal artery biopsy (TAB) proven GCA and developed central haziness OD>OS. Visual acuity worsened to 20/100 OD and 20/25 OS. Clinical exam, optical coherence tomography (OCT) and fluorescein angiography (FA) revealed central serous chorioretinopathy (CSCR). The patient was treated with focal laser therapy for CSCR and steroid taper. Patients with giant cell arteritis on high dose steroids may present with significant loss of visual acuity and field. CSCR (precipitated by steroids) should be considered in the differential diagnosis as increasing the steroid dose for presumed visual loss secondary to GCA might worsen rather than improve the visual outcome.

KW - Central serous retinopathy

KW - Chorioretinopathy

KW - Corticosteroid

KW - Giant cell arteritis

KW - Steroids

KW - Temporal arteritis

UR - http://www.scopus.com/inward/record.url?scp=33646937989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646937989&partnerID=8YFLogxK

U2 - 10.1080/08820530500511396

DO - 10.1080/08820530500511396

M3 - Article

C2 - 16517445

AN - SCOPUS:33646937989

VL - 21

SP - 45

EP - 48

JO - Seminars in Ophthalmology

JF - Seminars in Ophthalmology

SN - 0882-0538

IS - 1

ER -

Central serous chorioretinopathy in giant cell arteritis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this